Hamed Shahbazi
CIK 1942711 · last filed 2025-07-03
Hamed Shahbazi is a corporate insider who has filed 4 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing, for NAGE, was dated Jul 3, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAGE | Director | — | $3.45 | — | $0 | 1 | 2025-07-03 |
| Niagen Bioscience, Inc. (CDXC) Delisted | Director | — | $7.87 | — | $0 | 3 | 2024-06-24 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-03 | NAGE | Grant (A) | — | $0 | EDGAR |
| 2024-06-24 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-12 | Niagen Bioscience, Inc. (CDXC) Delisted | Grant (A) | — | $0 | EDGAR |